{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:00Z","timestamp":1792783980980,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008363","name":"The Danish Cancer Society","doi-asserted-by":"crossref","award":["R150-A10023"],"award-info":[{"award-number":["R150-A10023"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda","id":[{"id":"https:\/\/ror.org\/04hjbmv12","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Janssen"},{"name":"Famility Kj\u00e6rgaard Sunds"},{"name":"Odense University Hospital","id":[{"id":"https:\/\/ror.org\/00ey0ed83","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Non-response (NR) to patient-reported outcome (PRO) questionnaires may cause bias if not handled appropriately. Collecting reasons for NR is recommended, but how reasons for NR are related to missing data mechanisms remains unexplored. We aimed to explore this relationship for intermittent NRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with multiple myeloma completed validated PRO questionnaires at enrolment and 12 follow-up time-points. NR was defined as non-completion of a follow-up assessment within seven days, which triggered contact with the patient, recording the reason for missingness and an invitation to complete the questionnaire (denoted \u201csalvage response\u201d). Mean differences between salvage and previous on-time scores were estimated for groups defined by reasons for NR using linear regression with clustered standard errors. Statistically significant mean differences larger than minimal important difference thresholds were interpreted as \u201cmissing not at random\u201d (MNAR) mechanism (i.e. assumed to be related to declining health), and the remainder interpreted as aligned with \u201cmissing completely at random\u201d (MCAR) mechanism (i.e. assumed unrelated to changes in health).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most (7228\/7534 (96%)) follow-up questionnaires were completed; 11% (802\/7534) were salvage responses. Mean salvage scores were compared to previous on-time scores by reason: those due to hospital admission, mental or physical reasons were worse in 10\/22 PRO domains; those due to technical difficulties\/procedural errors were no different in 21\/22 PRO domains; and those due to overlooked\/forgotten or other\/unspecified reasons were no different in any domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intermittent NRs due to hospital admission, mental or physical reasons were aligned with MNAR mechanism for nearly half of PRO domains, while intermittent NRs due to technical difficulties\/procedural errors or other\/unspecified reasons generally were aligned with MCAR mechanism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11136-024-03707-y","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T10:01:10Z","timestamp":1718532070000},"page":"2387-2400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-3870","authenticated-orcid":false,"given":"Lene Kongsgaard","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-9099","authenticated-orcid":false,"given":"Rebecca","family":"Mercieca-Bebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-4269","authenticated-orcid":false,"given":"S\u00f6ren","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-2025","authenticated-orcid":false,"given":"Louise","family":"Redder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Jarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-6768","authenticated-orcid":false,"given":"Christen Lykkegaard","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8905-0220","authenticated-orcid":false,"given":"Henrik","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Svirskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Silkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Saaby","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Tr\u00f8llund","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Hinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Amdi","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Helleberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K\u00e6rsgaard","family":"Mylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6852-2014","authenticated-orcid":false,"given":"Niels","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2887","authenticated-orcid":false,"given":"Madeleine T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,16]]},"reference":[{"issue":"12","key":"3707_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/MLR.0b013e318268aaff","volume":"50","author":"S Ahmed","year":"2012","unstructured":"Ahmed, S., Berzon, R. A., Revicki, D. A., Lenderking, W. R., Moinpour, C. M., Basch, E., Reeve, B. B., & Wu, A. W. (2012). The use of patient-reported outcomes (PRO) within comparative effectiveness research: Implications for clinical practice and health care policy. Medical Care, 50(12), 1060\u20131070. https:\/\/doi.org\/10.1097\/MLR.0b013e318268aaff","journal-title":"Medical Care"},{"key":"3707_CR2","volume-title":"Quality of life: The assessment, analysis, and reporting of patient-reported outcomes","author":"PM Fayers","year":"2016","unstructured":"Fayers, P. M., & Machin, D. (2016). Quality of life: The assessment, analysis, and reporting of patient-reported outcomes (3rd ed.). Wiley.","edition":"3"},{"issue":"5","key":"3707_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/0962280213476378","volume":"23","author":"ML Bell","year":"2014","unstructured":"Bell, M. L., & Fairclough, D. L. (2014). Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Statistical Methods in Medical Research, 23(5), 440\u2013459. https:\/\/doi.org\/10.1177\/0962280213476378","journal-title":"Statistical Methods in Medical Research"},{"key":"3707_CR4","volume-title":"Chapman & Hall\/CRC interdisciplinary statistics series","author":"DL Fairclough","year":"2010","unstructured":"Fairclough, D. L. (2010). Design and analysis of quality of life studies in clinical trials. Chapman & Hall\/CRC interdisciplinary statistics series (2nd ed.). Chapman & Hall\/CRC.","edition":"2"},{"key":"3707_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1477-7525-7-57","volume":"7","author":"S Fielding","year":"2009","unstructured":"Fielding, S., Fayers, P. M., & Ramsay, C. R. (2009). Investigating the missing data mechanism in quality of life outcomes: A comparison of approaches. Health and Quality of Life Outcomes, 7, 57. https:\/\/doi.org\/10.1186\/1477-7525-7-57","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"3707_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin, D. B. (1976). Inference and missing data. Biometrika, 63(3), 581\u2013592. https:\/\/doi.org\/10.1093\/biomet\/63.3.581","journal-title":"Biometrika"},{"issue":"6","key":"3707_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010938","volume":"6","author":"R Mercieca-Bebber","year":"2016","unstructured":"Mercieca-Bebber, R., Palmer, M. J., Brundage, M., Calvert, M., Stockler, M. R., & King, M. T. (2016). Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: A systematic review. The BMJ Open, 6(6), e010938. https:\/\/doi.org\/10.1136\/bmjopen-2015-010938","journal-title":"The BMJ Open"},{"issue":"1","key":"3707_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1740774517741113","volume":"15","author":"MJ Palmer","year":"2018","unstructured":"Palmer, M. J., Mercieca-Bebber, R., King, M., Calvert, M., Richardson, H., & Brundage, M. (2018). A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data. Clinical Trials, 15(1), 95\u2013106. https:\/\/doi.org\/10.1177\/1740774517741113","journal-title":"Clinical Trials"},{"issue":"2","key":"3707_CR9","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/s1470-2045(19)30790-9","volume":"21","author":"C Coens","year":"2020","unstructured":"Coens, C., Pe, M., Dueck, A. C., Sloan, J., Basch, E., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Devlin, N., Dorme, L., Flechtner, H. H., Gotay, C., Griebsch, I., Groenvold, M., King, M., Kluetz, P. G., Koller, M., \u2026 Bottomley, A. (2020). International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: Recommendations of the SISAQOL consortium. The Lancet Oncology, 21(2), e83\u2013e96. https:\/\/doi.org\/10.1016\/s1470-2045(19)30790-9","journal-title":"The Lancet Oncology"},{"key":"3707_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2021.01.008","volume":"134","author":"KJ Lee","year":"2021","unstructured":"Lee, K. J., Tilling, K. M., Cornish, R. P., Little, R. J. A., Bell, M. L., Goetghebeur, E., Hogan, J. W., & Carpenter, J. R. (2021). Framework for the treatment and reporting of missing data in observational studies: The treatment and reporting of missing data in observational studies framework. Journal of Clinical Epidemiology, 134, 79\u201388. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.01.008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"3707_CR11","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle, R. A., & Rajkumar, S. V. (2008). Multiple myeloma. Blood, 111(6), 2962\u20132972. https:\/\/doi.org\/10.1182\/blood-2007-10-078022","journal-title":"Blood"},{"issue":"12","key":"3707_CR12","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., Landgren, O., Paiva, B., Dispenzieri, A., Weiss, B., LeLeu, X., Zweegman, S., Lonial, S., Rosinol, L., Zamagni, E., \u2026 Miguel, J. F. (2014). International myeloma working group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncology, 15(12), e538-548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"The Lancet Oncology"},{"issue":"5","key":"3707_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpainsymman.2012.11.003","volume":"46","author":"E Boland","year":"2013","unstructured":"Boland, E., Eiser, C., Ezaydi, Y., Greenfield, D. M., Ahmedzai, S. H., & Snowden, J. A. (2013). Living with advanced but stable multiple myeloma: A study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. Journal of Pain and Symptom Management, 46(5), 671\u2013680. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.11.003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"3707_CR14","doi-asserted-by":"publisher","first-page":"E73","DOI":"10.1002\/ajh.23932","volume":"90","author":"MO Holmstrom","year":"2015","unstructured":"Holmstrom, M. O., Gimsing, P., Abildgaard, N., Andersen, N. F., Helleberg, C., Clausen, N. A., Klausen, T. W., Frederiksen, M., Kristensen, D. L., Larsen, H., Pedersen, P. T., Andersen, K. T., Pedersen, R. S., Jensen, B. A., Gregersen, H., & Vangsted, A. J. (2015). Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish myeloma database. American Journal of Hematology, 90(4), E73-74. https:\/\/doi.org\/10.1002\/ajh.23932","journal-title":"American Journal of Hematology"},{"issue":"SUPPL 2","key":"3707_CR15","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0305-7372(10)70009-8","volume":"36","author":"MV Mateos","year":"2010","unstructured":"Mateos, M. V. (2010). Management of treatment-related adverse events in patients with multiple myeloma. Cancer Treatment Reviews, 36(SUPPL 2), S24\u2013S32.","journal-title":"Cancer Treatment Reviews"},{"issue":"4","key":"3707_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/leu.2011.346","volume":"26","author":"PG Richardson","year":"2012","unstructured":"Richardson, P. G., Delforge, M., Beksac, M., Wen, P., Jongen, J. L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S. V., Harousseau, J. L., Moreau, P., Avet-Loiseau, H., Lee, J. H., Cavo, M., Merlini, G., Voorhees, P., Chng, W. J., Mazumder, A., \u2026 Sonneveld, P. (2012). Management of treatment-emergent peripheral neuropathy in multiple myeloma. Leukemia, 26(4), 595\u2013608. https:\/\/doi.org\/10.1038\/leu.2011.346","journal-title":"Leukemia"},{"key":"3707_CR17","doi-asserted-by":"publisher","DOI":"10.1515\/sjpain-2020-0087","author":"E Jespersen","year":"2020","unstructured":"Jespersen, E., Nielsen, L. K., Larsen, R. F., M\u00f6ller, S., & Jarlb\u00e6k, L. (2020). Everyday living with pain\u2014Reported by patients with multiple myeloma. Scandinavian Journal of Pain. https:\/\/doi.org\/10.1515\/sjpain-2020-0087","journal-title":"Scandinavian Journal of Pain"},{"issue":"1","key":"3707_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/bjh.15759","volume":"185","author":"LK Nielsen","year":"2019","unstructured":"Nielsen, L. K., Abildgaard, N., Jarden, M., & Klausen, T. W. (2019). Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma. British Journal of Haematology, 185(1), 11\u201324. https:\/\/doi.org\/10.1111\/bjh.15759","journal-title":"British Journal of Haematology"},{"issue":"2","key":"3707_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11136-019-02304-8","volume":"29","author":"LK Nielsen","year":"2020","unstructured":"Nielsen, L. K., King, M., Moller, S., Jarden, M., Andersen, C. L., Frederiksen, H., Gregersen, H., Klostergaard, A., Steffensen, M. S., Pedersen, P. T., Hinge, M., Frederiksen, M., Jensen, B. A., Helleberg, C., Mylin, A. K., & Abildgaard, N. (2020). Strategies to improve patient-reported outcome completion rates in longitudinal studies. Quality of Life Research, 29(2), 335\u2013346. https:\/\/doi.org\/10.1007\/s11136-019-02304-8","journal-title":"Quality of Life Research"},{"issue":"5","key":"3707_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., & de Haes, J. C. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365\u2013376.","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"3707_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","volume":"43","author":"K Cocks","year":"2007","unstructured":"Cocks, K., Cohen, D., Wisloff, F., Sezer, O., Lee, S., Hippe, E., Gimsing, P., Turesson, I., Hajek, R., Smith, A., Graham, L., Phillips, A., Stead, M., Velikova, G., Brown, J., Group EQoL. (2007). An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. European Journal of Cancer (Oxford, England), 43(11), 1670\u20131678.","journal-title":"European Journal of Cancer (Oxford, England)"},{"issue":"11","key":"3707_CR22","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s11136-017-1626-1","volume":"26","author":"JM Kieffer","year":"2017","unstructured":"Kieffer, J. M., Postma, T. J., van de Poll-Franse, L., Mols, F., Heimans, J. J., Cavaletti, G., & Aaronson, N. K. (2017). Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20). Quality of Life Research, 26(11), 2999\u20133010. https:\/\/doi.org\/10.1007\/s11136-017-1626-1","journal-title":"Quality of Life Research"},{"key":"3707_CR23","unstructured":"Ware, J., Kosinski, M., & Keller, S. (1995). SF-12: How to score the SF-12 physical and mental summary scales. 2nd edition. The Health Institute, New England Medical Center."},{"issue":"2","key":"3707_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"Journal of Biomedical Informatics"},{"key":"3707_CR25","volume-title":"The EORTC QLQ-C30 scoring manual","author":"Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A., & on behalf of the EORTC Quality of Life Group","year":"2001","unstructured":"Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A., & on behalf of the EORTC Quality of Life Group. (2001). The EORTC QLQ-C30 scoring manual (3rd ed.). European Organisation for Research and Treatment of Cancer.","edition":"3"},{"key":"3707_CR26","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum Associates.","edition":"2"},{"issue":"6","key":"3707_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF00439229","volume":"5","author":"MT King","year":"1996","unstructured":"King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555\u2013567.","journal-title":"Quality of Life Research"},{"key":"3707_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-79","author":"AK Kvam","year":"2010","unstructured":"Kvam, A. K., Wisloff, F., & Fayers, P. M. (2010). Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma. Health and Quality of Life Outcomes. https:\/\/doi.org\/10.1186\/1477-7525-8-79","journal-title":"Health and Quality of Life Outcomes"},{"issue":"1","key":"3707_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/jco.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks, K., King, M. T., Velikova, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30. Journal of Clinical Oncology, 29(1), 89\u201396. https:\/\/doi.org\/10.1200\/jco.2010.28.0107","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"3707_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jclinepi.2009.05.001","volume":"63","author":"MT King","year":"2010","unstructured":"King, M. T., Stockler, M. R., Cella, D. F., Osoba, D., Eton, D. T., Thompson, J., & Eisenstein, A. R. (2010). Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G. Journal of Clinical Epidemiology, 63(3), 270\u2013281. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.05.001","journal-title":"Journal of Clinical Epidemiology"},{"key":"3707_CR31","doi-asserted-by":"publisher","unstructured":"National Research Council Panel on Handling Missing Data in Clinical, T. (2010). The prevention and treatment of missing data in clinical trials. National Academies Press (US) Copyright 2010 by the National Academy of Sciences. All rights reserved, Washington (DC). https:\/\/doi.org\/10.17226\/12955","DOI":"10.17226\/12955"},{"issue":"12","key":"3707_CR32","first-page":"784","volume":"38","author":"PW Lavori","year":"2008","unstructured":"Lavori, P. W., Brown, C. H., Duan, N., Gibbons, R. D., & Greenhouse, J. (2008). Missing data in longitudinal clinical trials part A: Design and conceptual issues. Psychiatric Annnals, 38(12), 784\u2013792.","journal-title":"Psychiatric Annnals"},{"key":"3707_CR33","unstructured":"Chowdhry, A.K., Gondi, V., & Pugh, S. L. Missing data in clinical studies (1879-355X (Electronic))"},{"key":"3707_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12982-017-0068-0","volume":"14","author":"RP Cornish","year":"2017","unstructured":"Cornish, R. P., Macleod, J., Carpenter, J. R., & Tilling, K. (2017). Multiple imputation using linked proxy outcome data resulted in important bias reduction and efficiency gains: A simulation study. Emerging Themes in Epidemiology, 14, 14. https:\/\/doi.org\/10.1186\/s12982-017-0068-0","journal-title":"Emerging Themes in Epidemiology"},{"issue":"1","key":"3707_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12955-019-1181-2","volume":"17","author":"OF Ayilara","year":"2019","unstructured":"Ayilara, O. F., Zhang, L., Sajobi, T. T., Sawatzky, R., Bohm, E., & Lix, L. M. (2019). Impact of missing data on bias and precision when estimating change in patient-reported outcomes from a clinical registry. Health and Quality of Life Outcomes, 17(1), 106. https:\/\/doi.org\/10.1186\/s12955-019-1181-2","journal-title":"Health and Quality of Life Outcomes"},{"issue":"14","key":"3707_CR36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","volume":"367","author":"RJ Little","year":"2012","unstructured":"Little, R. J., D\u2019Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., Neaton, J. D., Rotnitzky, A., Scharfstein, D., Shih, W. J., Siegel, J. P., & Stern, H. (2012). The prevention and treatment of missing data in clinical trials. The New England Journal of Medicine, 367(14), 1355\u20131360. https:\/\/doi.org\/10.1056\/NEJMsr1203730","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"3707_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","volume":"319","author":"M Calvert","year":"2018","unstructured":"Calvert, M., Kyte, D., Mercieca-Bebber, R., Slade, A., Chan, A. W., King, M. T., Hunn, A., Bottomley, A., Regnault, A., Chan, A. W., Ells, C., O\u2019Connor, D., Revicki, D., Patrick, D., Altman, D., Basch, E., Velikova, G., Price, G., Draper, H., \u2026 Groves, T. (2018). Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension. The Journal of the American Medical Association, 319(5), 483\u2013494. https:\/\/doi.org\/10.1001\/jama.2017.21903","journal-title":"The Journal of the American Medical Association"},{"key":"3707_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/prom.S178963","volume":"10","author":"ML Bell","year":"2019","unstructured":"Bell, M. L., Floden, L., Rabe, B. A., Hudgens, S., Dhillon, H. M., Bray, V. J., & Vardy, J. L. (2019). Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies. Patient Related Outcome Measures, 10, 129\u2013140. https:\/\/doi.org\/10.2147\/prom.S178963","journal-title":"Patient Related Outcome Measures"},{"issue":"1","key":"3707_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12874-020-01180-y","volume":"21","author":"G Carreras","year":"2021","unstructured":"Carreras, G., Miccinesi, G., Wilcock, A., Preston, N., Nieboer, D., Deliens, L., Groenvold, M., Lunder, U., van der Heide, A., & Baccini, M. (2021). Missing not at random in end of life care studies: Multiple imputation and sensitivity analysis on data from the ACTION study. BMC Medical Research Methodology, 21(1), 13. https:\/\/doi.org\/10.1186\/s12874-020-01180-y","journal-title":"BMC Medical Research Methodology"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-024-03707-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T09:16:56Z","timestamp":1726046216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-024-03707-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3707"],"URL":"https:\/\/doi.org\/10.1007\/s11136-024-03707-y","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,16]]},"assertion":[{"value":"30 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was approved by the Danish Data Protection Agency, registered at ClinicalTrials.gov by number NCT02892383 and carried out in accordance with the Helsinki Declaration and Good Clinical Practice guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}